SBP-0636457, a Novel Smac Mimetic, Cooperates with Doxorubicin to Induce Necroptosis in Breast Cancer Cells during Apoptosis Blockage

Breast cancer (BC) is a common health concern worldwide. Doxorubicin (Dox) is a widely used chemotherapeutic agent to treat various cancers, including BC. However, drug resistance and severe side effects often hinder the clinical application of Dox. Combination therapy is an effective potent strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Rui, Wang, Lei, Ji, Xiaochun, Mao, Chenxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293568/
https://www.ncbi.nlm.nih.gov/pubmed/35859663
http://dx.doi.org/10.1155/2022/2390078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293568/
https://www.ncbi.nlm.nih.gov/pubmed/35859663
http://dx.doi.org/10.1155/2022/2390078

Ejemplares similares